Pursuant to reg. 30 of the listing regulations; it is hereby informed that the Company has received 1 Purchase Order as below:1. Haffkine Bio Pharmaceutical Corporation Limited (A Government of Maharashtra Undertaking for Product named Multipara Monitor with NIBP with Neonates and Pediatric Probe.The details as per point. 04 of Annexure II of SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13 2023 on Continuous Disclosure Requirements for Listed Entities- Regulation 30 of SEBI (LODR) Regulations 2015 are attached as Annexure - I.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
